High-dose group:oral high-dose BJY-802, one time and one bag, three times a day, one time in the morning, one time in the evening, and used continuously for 8 weeks

A multicenter, randomized, double-blind, placebo parallel control phase IIb study of the efficacy and safety of BJY-802 in the treatment of stable angina pectoris (qi deficiency blood stasis)

A multicenter, randomized, double-blind, placebo parallel control phase IIb study of the efficacy and safety of BJY-802 in the treatment of stable angina pectoris (qi deficiency blood stasis)